Molecular probes for multimodality imaging and tracking of stem cells
The invention relates to novel multi-modality probes for imaging, tracking and analyzing stem cells and related biological samples, and methods of preparation and use thereof. The molecular probes of the invention are constructed, for example, by utilizing (a) the high selectivity of long hydrocarbon chains for binding to plasma membranes of cells, (b) a near-infrared (NIR) dye for optical imaging, and (c) a radionuclide for PET or SPECT imaging. The in vitro and in vivo data of the optical and radiolabeled probes demonstrated their utility for detecting the presence of stem cells with multiple imaging modalities.
1. A compound having the formula:
wherein
B is a chelating moiety capable of complexing to a radioactive metal;
R and R 1 are substituent groups independently selected from the group consisting of alkyl, alkenyl, alkynyl, alkaryl and aralkyl, each of R and R 1 comprising one or more linear or branched hydrocarbon chains having from about 2 to about 30 carbon atoms, and each of R and R 1 being unsubstituted or substituted with one or more non-polar functional groups;
L comprises a fluorophore with emission in the range from about 650 nm to about 850 nm;
R 2 is a spacer moiety having the formula:
—(R 3 ) p -Q-(R 4 -Q′) q -(R 5 -Q″) r -(R 6 -Q′″) s -(R 7 Q″″) t ,
wherein
R 3 is an aliphatic hydrocarbon, R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of aliphatic, alicyclic or aromatic hydrocarbons, heterocycles or CH 2 C(CO 2 H)═CH,
Q, Q′, Q″, Q′″ and Q″″ are linking groups independently selected from the group consisting of amide, thiourea, hydrazone, acylhydrazone, ketal, acetal, orthoester, ester, anhydride, disulfide, urea, carbamate, imine, amine, ether, carbonate, thioether, sulfonamide, carbonyl, amidine and triazine, a valence bond, the aliphatic or alicyclic hydrocarbons having from about 1 to about 12 linear carbon atoms, and the aromatic hydrocarbons having from about 6 to about 12 carbon atoms;
p, q, r, s and t each is 0 or 1; and
n is 0 or 1.
2. The compound of claim 1 , wherein B is complexed to 111 In ion.
3. The compound of claim 1 , having the formula:
wherein
Z is a substituent selected from the group consisting of H, alkyl, OH, O-alkyl, COOH, CONH 2 , SO 3 H, SO 2 NH 2 , CONH-alkyl, CON(alkyl) 2 , NH-acyl, NH-alkyl, N(alkyl) 2 , SH, S-alkyl, NO 2 , halogen, Si(alkyl) 3 and O—Si(alkyl) 3 , wherein the alkyl groups independently comprising from 1 to 4 carbon atoms;
y is 2 or 3; and
A is a biologically compatible counter anion.
4. The compound of claim 3 , wherein B is complexed to 111 In ion.
5. The compound of claim 1 , having the formula:
wherein
Z is a substituent selected from the group consisting of H, alkyl, OH, O-alkyl, COOH, CONH 2 , SO 3 H, SO 2 NH 2 , CONH-alkyl, CON(alkyl) 2 , NH-acyl, NH-alkyl, N(alkyl) 2 , SH, S-alkyl, NO 2 , halogen, Si(alkyl) 3 and O—Si(alkyl) 3 , wherein the alkyl groups independently comprising from about 1 to about 4 carbon atoms;
X is a substituent selected from the group consisting of H, halogen, phenoxy, thiophenoxy and aryl; and
A is a biologically compatible counter anion.
6. The compound of claim 5 , wherein B is complexed to 111 In ion.
7. The compound of claim 1 , having the formula:
wherein
Z is a substituent selected from the group consisting of H, alkyl, OH, O-alkyl, COOH, CONH 2 , SO 3 H, SO 2 NH 2 , CONH-alkyl, CON(alkyl) 2 , NH-acyl, NH-alkyl, N(alkyl) 2 , SH, S-alkyl, NO 2 , halogen, Si(alkyl) 3 and O—Si(alkyl) 3 , wherein the alkyl groups independently comprising from about 1 to about 4 carbon atoms.
8. The compound of claim 7 , wherein B is complexed to 111 In ion.
9. The compound of claim 1 , having the formula:
wherein
Z is a substituent selected from the group consisting of H, alkyl, OH, O-alkyl, COOH, CONH 2 , SO 3 H, SO 2 NH 2 , CONH-alkyl, CON(alkyl) 2 , NH-acyl, NH-alkyl, N(alkyl) 2 , SH, S-alkyl, NO 2 , halogen, Si(alkyl) 3 and O—Si(alkyl) 3 , wherein the alkyl groups independently comprising from about 1 to about 4 carbon atoms.
10. The compound of claim 9 , wherein B is complexed to 111 In ion.
11. The compound of claim 1 , having the formula:
wherein
Z is a substituent selected from the group consisting of H, alkyl, OH, O-alkyl, COOH, CONH 2 , SO 3 H, SO 2 NH 2 , CONH-alkyl, CON(alkyl) 2 , NH-acyl, NH-alkyl, N(alkyl) 2 , SH, S-alkyl, NO 2 , halogen, Si(alkyl) 3 and O—Si(alkyl) 3 , wherein the alkyl groups independently comprising from about 1 to about 4 carbon atoms; and
X is a substituent selected from the group consisting of H, halogen, phenoxy, thiophenoxy and aryl.
12. The compound of claim 11 , wherein B is complexed to 111 In ion.
13. The compound of claim 1 , having the formula
wherein
Z is a substituent selected from the group consisting of H, alkyl, OH, O-alkyl, COOH, CONH 2 , SO 3 H, SO 2 NH 2 , CONH-alkyl, CON(alkyl) 2 , NH-acyl, NH-alkyl, N(alkyl) 2 , SH, S-alkyl, NO 2 , halogen, Si(alkyl) 3 and O—Si(alkyl) 3 , wherein the alkyl groups independently comprising from about 1 to about 4 carbon atoms.
14. The compound of claim 13 , wherein B is complexed to 111 In ion.
15. The compound of claim 1 chelated to an 111 In ion, with the formed complex having the formula:
16. The compound of claim 1 chelated to an 111 In ion, with the formed complex having the formula:
17. The compound of claim 1 chelated to an 111 In ion, with the formed complex having the formula:
18. The compound of claim 1 chelated to an 111 In ion, with the formed complex having the formula:
19. A method for imaging, tracking and/or analyzing cells, comprising:
labeling a sample of cells with a compound of claim 1 ; and
imaging the cells via two or more modalities comprising optical imaging and radiological imaging.
20. The method of claim 19 , wherein the cells are stem cells.